In vitro and in vivo analysis of B-Myb in basal-like breast cancer
about
Novel Molecular Markers for Breast CancerPotential tumor suppressor role for the c-Myb oncogene in luminal breast cancer.Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts.B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer.ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.The DREAM complex: master coordinator of cell cycle-dependent gene expression.B-myb is a gene implicated in cell cycle and proliferation of breast cancerSystems biology and genomics of breast cancer.Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB.An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cellsDifferential network analysis applied to preoperative breast cancer chemotherapy response.B-Myb, cancer, senescence, and microRNAs.Overexpression of Raf-1 in basal-like carcinoma of the breast: correlation with clinicopathology and prognosis.Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis.MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.Basal breast cancer: a complex and deadly molecular subtypeGene expression in "young adult type" breast cancer: a retrospective analysis.Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes.The Major Prognostic Features of Nuclear Receptor NR5A2 in Infiltrating Ductal Breast Carcinomas.OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancerMyb proteins: angels and demons in normal and transformed cells.Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.The complex containing Drosophila Myb and RB/E2F2 regulates cytokinesis in a histone H2Av-dependent mannerA supervised network analysis on gene expression profiles of breast tumors predicts a 41-gene prognostic signature of the transcription factor MYB across molecular subtypes.SWIM: a computational tool to unveiling crucial nodes in complex biological networks.Situational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis.Construction of an integrated gene regulatory network link to stress-related immune system in cattle.B-Myb enhances proliferation and suppresses differentiation of keratinocytes in three-dimensional cell culture.The molecular basis of breast cancer pathological phenotypes.Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome.Annotation enrichment analysis: an alternative method for evaluating the functional properties of gene sets.RAS, cellular senescence and transformation: the BRCA1 DNA repair pathway at the crossroads.Prognostic value of proliferation markers expression in breast cancer.Refinement of breast cancer risk prediction with concordant leading edge subsets from prognostic gene signatures.MuvB: A Key to Cell Cycle Control in Ovarian Cancer.B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis
P2860
Q26753160-1DE9C437-463D-44FD-A1A6-AADE7DBF1A95Q33719480-521023C3-5C97-4188-9249-55074B4079DBQ33742688-0FAC2AEE-E2EF-4999-9593-F159E8C9B598Q33838305-D1543988-E126-42BB-AD18-27DA553EDAB5Q34316094-056903E2-4312-4EFC-A9C9-09C71C9725CFQ34356659-62C4B400-BE34-47F9-BEFE-ECDAEA267803Q34371386-76F2DAEB-9945-4DA0-B1F9-23BEBF823982Q34576377-1CE62FEC-67EE-435D-9CF9-D0A06F7D713EQ34649841-A69834A7-1ECB-4D86-BE6D-5521208BCE1BQ34989075-1F420903-FC45-4DA1-B09F-171172A9AA91Q35000256-1C92EEA0-49B0-4342-AB30-468618D7A8DDQ35069778-B7889E5D-C52B-448D-BB46-DC6F4AB11931Q35164933-E7403D47-765B-4C09-B6CD-897FDBCA5B42Q35165561-5440B34B-7B5D-494E-986D-909C018AEEA2Q35750136-736E1800-B561-4571-BAFA-F3177C81B435Q35758028-2DEEE742-E946-4D78-BE9C-2168AE7D3635Q35931900-4FA239BA-65BC-4778-B2AE-58A2EEF082D2Q35955416-AE55BBFD-2AF6-435A-8B05-2172B29C1BE1Q35970493-3C30DC53-7F0F-472A-A857-DAC5AAD67851Q36031258-2E7EB360-7DBC-4205-8093-52E89EEBC758Q36260580-17C4ACA9-1996-4795-AE3A-B37D7B911C77Q36603616-E2A55144-939F-47C3-98C9-9816264DF50EQ36603829-84CF1FF7-131B-46F9-899D-09DAFDC8396EQ36759668-8A01C991-8F1C-4ACE-A5E1-22AE552A5479Q37594954-A575B326-BABF-4C1F-A0BB-1CC01E61BAABQ37710898-A92E990D-3705-4560-9CD2-07AEDF620530Q38256411-EE23D8FC-0E59-4C50-9308-21D264CE3154Q38616441-A0FCC1B4-816D-4141-9A78-E3F97209576CQ39025092-7D2523EB-4843-4608-912E-DE557C2A0D15Q39175548-1992419F-255F-4DE2-A05C-785B7C1BD4B1Q39743981-1794AFB2-ABB6-4EA9-B69B-9B689C28A7AFQ41786087-B8EC7C95-CD3B-4C3B-B6A9-48DEA3C07389Q41808393-D64E6EF2-F79C-4669-8779-8710A049D32DQ43692538-BEFEFC6E-E553-43CC-87AB-16955AF9BA73Q51049666-C87FF17A-A8DC-4346-BE4B-43A671AFB336Q55286778-8DBBAFED-7A0A-4F82-B36B-46F4FAD912B5Q55302816-5D10DE4B-FDB9-453F-AA84-8EF1053B313EQ57283070-F187FAF6-CC2D-4D5F-B5A2-1699C7A55FD1
P2860
In vitro and in vivo analysis of B-Myb in basal-like breast cancer
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
In vitro and in vivo analysis of B-Myb in basal-like breast cancer
@en
type
label
In vitro and in vivo analysis of B-Myb in basal-like breast cancer
@en
prefLabel
In vitro and in vivo analysis of B-Myb in basal-like breast cancer
@en
P2093
P2860
P356
P1433
P1476
In vitro and in vivo analysis of B-Myb in basal-like breast cancer
@en
P2093
A R Thorner
J S Parker
K A Hoadley
R C Millikan
P2860
P2888
P304
P356
10.1038/ONC.2008.430
P407
P577
2008-12-01T00:00:00Z
P5875
P6179
1006680608